Traversa Therapeutics Company Profile

News Articles [ 2 Associated News Articles listed on BioPortfolio]

Relmada Therapeutics To Present At The Biotech Showcase™ 2013

BLUE BELL, Pa., Jan. 4, 2013 /PRNewswire/ -- Relmada Therapeutics, a clinical-stage company developing novel therapies for the treatment of chronic pain, today announced that Sergio Traversa, the comp...

Relmada Therapeutics Gears Up To Become A Publicly Traded Company

NEW YORK, May 20, 2013 /PRNewswire/ -- Relmada Therapeutics, Inc., a clinical-stage company developing novel therapies for the treatment of chronic pain, today announced that has retained Brio Fi...

Drugs and Medications [0 Results]

None

PubMed Articles [ 6 Associated PubMed Articles listed on BioPortfolio]

Stability of the Ce(3+) valence state in cerium oxide nanoparticle layers.

A high concentration of Ce(3+) ions, above 80%, was created in 5 nm thick cerium oxide nanoparticle (nanoceria) layers deposited on a polymer substrate. The reduction from Ce(4+) to Ce(3+) was achieve...

Catalytic, asymmetric hypervinylogous mukaiyama aldol reactions of extended furan-based silyl enolates.

Virtually perfect transmittal of the enolate reactivity up to five conjugated double bonds from the origin allows a series of furan-based silyloxypolyenes to add to aldehyde carbonyls at the most dist...

Lowering grain boundary resistance of BaZr(0.8)Y(0.2)O(3-δ) with LiNO(3) sintering-aid improves proton conductivity for fuel cell operation.

A novel sintering additive based on LiNO(3) was used to overcome the drawbacks of poor sinterability and low grain boundary conductivity in BaZr(0.8)Y(0.2)O(3-δ) (BZY20) protonic conductors. The Li-a...

Antioxidant treatments counteract the non-culturability of bacterial endophytes isolated from legume nodules.

In many wild legumes, attempts to cultivate nodule bacteria fail. We hypothesized that the limited culturability could be related to injury from oxidative stress caused by disruption of plant tissues...

Control of postharvest diseases of fruit by heat and fungicides: efficacy, residue levels, and residue persistence. A review.

Extensive research has been done in recent years to reduce the heavy dependence on chemical fungicides to control postharvest diseases and disorders of horticultural crops. Alternative strategies were...

Clinical Trials [0 Results]

None

Companies [ 2 Associated Companies listed on BioPortfolio]

Traversa Therapeutics

Traversa Therapeutics, Inc. (www.traversathera.com) is a San Diego, California-based biopharmaceutical company engaged in the discovery, development and commercialization of RNAi...

Traversa Therapeutics, Inc.